Psyence Biomedical Ltd. (PBM) shareholders
PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30
$4.12−0.10 (-2.37%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
9
7 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Psyence Labs Ltd. | 2,643,659 | 49.75% | 13D (active) amendment | Oct 1, 2026 |
| Hudson Bay Capital Management LP | 380,000 | 9.98% | 13G (passive) | Dec 31, 2024 |
| AdvisorShares Trust | 258,538 | 6.78% | 13G (passive) | Sep 30, 2026 |
| Harraden Circle Investors GP, LLC Joint filing with Harraden Circle Investments, LLC (5.32%), Harraden Circle Investors GP, LP (5.32%) and 1 more | 182,323 | 5.32% | 13G (passive) amendment | Dec 31, 2024 |
| White Lion Capital, LLC | 100,000 | 8.93% | 13G (passive) | Dec 4, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PBM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 151,250 | – | $574.75K | – | 0.01% |
| AdvisorShares Investments LLC | 122,184 | – | $373.88K | New | 0.05% |
| Morgan Stanley | 37,804 | – | $115.68K | New | 0.00% |
| Jane Street Group, LLC | 30,431 | – | $93.12K | New | 0.00% |
| XTX Topco Ltd | 15,094 | – | $46.19K | New | 0.00% |
| Citadel Advisors LLC | 11,693 | – | $35.78K | New | 0.00% |
| Stonehage Fleming Financial Services Holdings Ltd | 89 | – | $272 | – | 0.00% |
| UBS Group AG | 60 | – | $184 | New | 0.00% |
| Caitlin John, LLC | 35 | – | $107 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 7 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 2 | 0M | 1 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PBM | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 122,184 | – | $373.88K | 0.84% | Jun 30, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-6.1%
From 0M shares
Short volume, 20 days
29.2%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Psyence Biomedical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,581 shares on Aug 24, 2026 over the last 90 days.
See a number that looks wrong?